1. Home
  2. GKOS vs ASLE Comparison

GKOS vs ASLE Comparison

Compare GKOS & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$103.21

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo AerSale Corporation

ASLE

AerSale Corporation

N/A

Current Price

$6.32

Market Cap

296.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
ASLE
Founded
1998
2008
Country
United States
United States
Employees
1094
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
296.8M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
GKOS
ASLE
Price
$103.21
$6.32
Analyst Decision
Strong Buy
Hold
Analyst Count
14
2
Target Price
$133.07
$7.00
AVG Volume (30 Days)
634.7K
254.9K
Earning Date
04-29-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.64
EPS
N/A
0.18
Revenue
$507,442,000.00
$335,286,000.00
Revenue This Year
$23.39
$24.23
Revenue Next Year
$27.46
$23.67
P/E Ratio
N/A
$35.08
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$5.56
52 Week High
$130.23
$9.08

Technical Indicators

Market Signals
Indicator
GKOS
ASLE
Relative Strength Index (RSI) 41.71 27.72
Support Level $81.54 $5.69
Resistance Level $113.50 $6.56
Average True Range (ATR) 3.93 0.24
MACD -0.78 -0.08
Stochastic Oscillator 31.42 9.57

Price Performance

Historical Comparison
GKOS
ASLE

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

Share on Social Networks: